跳至主要内容
临床试验/NL-OMON53362
NL-OMON53362已完成不适用

The incorporation of dietary protein derived amino acids in duodenal epithelium in young and older males. - GutFeeding study

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 16 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Male sex
  • - Aged 18-35 years or 67+ years
  • - Body mass index (BMI) between 18.5 and 30 kg/m2

排除标准

  • - History of cardiovascular, respiratory, gastrointestinal, urogenital,
  • neurological, psychiatric, dermatologic, musculoskeletal, metabolic, endocrine,
  • haematological, immunologic disorders, allergy, major surgery and/or laboratory
  • assessments which might limit participation in or completion of the study
  • protocol, interfere with the execution of the experiment, or potential
  • influence the study outcomes (to be decided by the principal investigator and
  • responsible physician)
  • - Major abdominal surgery interfering with gastrointestinal function (upon
  • judgement of the principal investigator and responsible physician)
  • - Use of medication which limit participation in or completion of the study
  • protocol, interferes with the execution of the experiment, or potential
  • influences the study outcomes (to be decided by the principal investigator and
  • responsible physician)
  • - Use of supplementation (i.e. vitamin, pre- and probiotic supplementation)
  • within 14 days prior to testing
  • - Administration of investigational drugs or participation in any scientific
  • intervention study in the 14 days prior to the study, which may interfere with
  • this study (upon judgement of the principal investigator and responsible
  • - Specific diet (e.g. vegetarian, vegan, gluten free, no diary) within the
  • study period
  • - Planning to lose weight during the study period
  • - Lactose intolerance
  • - Excessive alcohol consumption (defined as > 14 alcoholic consumptions per
  • - Drug use
  • - Donated blood two months prior to the test day
  • - Recent (<1 year) participation in amino acid tracer
  • (L-[ring-2H5]-phenylalanine, L-[ring-2H3]-leucine, L-[ring-2H4]-lysine,
  • L-[ring-2H2]-tyrosine) or intrinsically labelled protein
  • ([1-13C]-phenylalanine, [1-13C]-leucine, [1-13C]-lysine) studies
  • - No given permission to register participation in electronic patient file at
  • MUMC+ and to add records of gastroduodenoscopy

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验